Variants in genes like FTO and MC4R can influence how quickly patients lose weight and how their metabolic rate adjusts to GLP-1 therapy
N Engl J Med 381(9):841851 Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD, Lam CSP, Khurmi NS, Heenan L, Del Prato S et al (2021) Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes
Mazzone SB, Undem BJ
However, this case lacks a temperature display, making it difficult to determine the exact temperature of your meds
Some of the negative microbial signatures for GLP-1 RA treatment in T2D patients might be related to diseases
Ruiz-Pozo et al., 2023) The PI3K/Akt pathway is also responsible for regulating protein clearance systems like autophagy and the ubiquitin-proteasome system